Multiple sclerosis following splenectomy as a treatment for idiopathic thrombocytopenic purpura.

A 27-year-old woman was admitted to our hospital with tetraparesis, dysesthesia and hypoesthesia of all regions below the breasts, urinary disturbance, and difficulty in breathing. Since age 21 idiopathic thrombocytopenic purpura (ITP) was diagnosed and steroid therapy was continued. At age 26, she had splenectomy for her ITP. On admission, steroid pulse therapy was administered with a tentative diagnosis of transverse myelitis. Symptoms gradually ameliorated. At age 29, she gradually lost her left vision, and multiple sclerosis was diagnosed and steroid therapy was administered, and her left vision gradually ameliorated. There are several reports describing other autoimmune disorders that arise after splenectomy. Since the spleen acts as a major pool of type 2 helper T cells, it is plausible that peripheral type 1 helper T cell activity may increase after splenectomy, promoting the development of autoimmune disorders. We considered there would be a close relation between splenectomy for ITP and multiple sclerosis in this case.

[1]  H. Weiner.  Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. , 2004, Archives of neurology.

[2]  A. Chaudhuri,et al.  Multiple sclerosis is not an autoimmune disease. , 2004, Archives of neurology.

[3]  Y. Ikeda,et al.  Spleen Is a Primary Site for Activation of Platelet-Reactive T and B Cells in Patients with Immune Thrombocytopenic Purpura1 , 2002, The Journal of Immunology.

[4]  Y. Ikeda,et al.  Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. , 2001, Blood.

[5]  R. Mcmillan.  Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. , 2000, Seminars in hematology.

[6]  M. Mazzucconi,et al.  Long‐term follow‐up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy , 1999, European journal of haematology.

[7]  J. George,et al.  Workshop on autoimmune (idiopathic) thrombocytopenic purpura: Pathogenesis and new approaches to therapy , 1998, American journal of hematology/oncology.

[8]  J. Freedman,et al.  Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. , 1996, Blood.

[9]  H. Kauffman,et al.  Suppressor activity of the human spleen and thymus. , 1976, Surgery.

[10]  H. Kauffman,et al.  THE HUMAN SPLENIC SUPPRESSOR CELL , 1975, Transplantation.

[11]  A. Allison,et al.  Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. , 1971, Lancet.

[12]  A. Antenucci,et al.  Modifications of lymphocyte subsets in autoimmune thrombocytopenic purpura patients submitted to splenectomy. , 2000, Haematologica.

[13]  H. Joshua,et al.  Autoimmune antibodies after splenectomy. , 1980, Acta haematologica.

[14]  W. Best,et al.  A critical look at the splenectomy-S.L.E. controversy. , 1962, The Medical clinics of North America.